Neural Analytics Inc. Announces The Appointment Of Dr. Neil A. Martin As Chief Medical Officer

LOS ANGELES--(BUSINESS WIRE)--Neural Analytics, a medical device company focusing on developing devices and services to measure, diagnose and track brain health and concussions, announced the appointment of Dr. Neil A. Martin as chief medical officer.

As the chairman and W. Eugene Stern Professor in Neurosurgery in the UCLA Department of Neurosurgery, Dr. Martin comes to Neural Analytics with extensive experience in research and treatment of brain injury and neurovascular disorders, including aneurysm, stroke and arteriovenous malformation.

Suggested Articles

Outgoing BIO Chair John Maraganore and his successor, Jeremy Levin, reflected on drug pricing, its drivers and its place in the innovation ecosystem.

The study is assessing the effect of the oral AXL inhibitor when given to elderly AML patients in combination with low-intensity chemotherapy.

The proportion of patients who had a greater than 1 g/dL increase in hemoglobin is down on GBT’s prior update but still superior to placebo.